Radiofrequency ablation safe, effective for medically inoperable NSCLC

Radiofrequency ablation conferred 2-year OS rates comparable to stereotactic body radiotherapy in patients with medically inoperable non–small cell lung cancer, according to study results. Further, radiofrequency ablation appeared safe and did not adversely affect pulmonary function tests, the study also found.